Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical genetics in transition-a comparison of genetic services in Estonia, Finland, and the Netherlands.

Journal of community genetics·2021
Same author

Prolonged survival in a patient with a novel pyrroline-5-carboxylase reductase 2 genetic variant.

European journal of neurology·2019
Same author

Analysis of (CAG)<sub>n</sub> expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy.

Scientific reports·2018
Same author

"I would like to discuss it further with an expert": a focus group study of Finnish adults' perspectives on genetic secondary findings.

Journal of community genetics·2018
Same author

Spinocerebellar ataxia type 10: common haplotype and disease progression rate in Peru and Brazil.

European journal of neurology·2017
Same author

The potential benefits of genetic testing in breast and ovarian cancer.

Saudi medical journal·2016
Same journal

Optimizing reporting and outreach for surveillance and risk-reducing surgeries for cancer genetic predisposition: Findings of a workshop organized by the International Cascade Consortium.

Public health genomics·2026
Same journal

Key outcomes from a stakeholder workshop on genomic newborn screening: recommended next steps for the integration of genomics into public health programs.

Public health genomics·2026
Same journal

The IMPACT-FH Renewal Protocol: Evaluating FH Cascade Testing Implementation in Primary Care through a Pragmatic Trial, Economic Evaluation, and Mixed-Methods Sustainability Assessment.

Public health genomics·2026
Same journal

Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening.

Public health genomics·2026
Same journal

Family Leaders Navigate Burden to Communicate Risk During Cascade Screening after Sudden Cardiac Death in the Young.

Public health genomics·2026
Same journal

Adolescent and Young Adult Perspectives on Receiving Pathogenic or Likely Pathogenic Results in a Prospective Genomic Screening Clinical Trial.

Public health genomics·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Genetic screening in Europe.

P Javaher1, E Nyoungui, H Kääriäinen

  • 1Department of Human Genetics, Hannover Medical School, Hannover, Germany. javaher.poupak@mh-hannover.de

Public Health Genomics
|March 6, 2010
PubMed
Summary
This summary is machine-generated.

Genetic screening systematically detects genetic diseases or predispositions in populations, including prenatal and neonatal screening. This survey examines current European genetic screening programs to aid harmonization efforts.

More Related Videos

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

Area of Science:

  • Medical Genetics
  • Public Health

Background:

  • Genetic screening systematically detects genetic diseases or predispositions.
  • Distinguishes screening from genetic testing, emphasizing population-based applications like prenatal and neonatal screening.

Purpose of the Study:

  • To present the current status (2006-2008) of genetic screening and its program organization in selected European countries.
  • To provide a background for harmonizing genetic screening standards and procedures within the European Network of Excellence, EuroGentest.

Main Methods:

  • Survey of genetic screening programs in selected European countries.
  • Building upon previous comprehensive assessments of genetic screening in Germany.

Main Results:

  • Presents the 2006-2008 status of genetic screening programs.
  • Details the organization of these programs across various European nations.

Conclusions:

  • Highlights the need for harmonized standards and procedures in European genetic screening.
  • Emphasizes the role of EuroGentest in advancing genetic screening harmonization.